Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

Author： Castro A.   Martinez A.  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.10, 2000-10, pp. : 1519-1527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

Tocopherol (Vitamin E) in Alzheimer’s Disease and Other Neurodegenerative Disorders

By Karen Berman   Henry Brodaty  

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 807-825

Adis International

Access to resources Recommend Favorite

Tau Protein Phosphorylation as a Therapeutic Target in Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite

Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 25, Iss. 27, 2018-08 ,pp. : 3228-3246

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical treatment for cognitive deficits in Alzheimer’s disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps

By Bartus Raymond   Dean Reginald  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 15-36

Springer Publishing Company

Access to resources Recommend Favorite